Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel,Gemcitabine,Sunitinib
Sponsor: Jungsil Ro
Collaborators: Pfizer|HK inno.N Corporation